- Home
- CNTA vs VFC Comparison
CNTA vs VFC Comparison
Compare CNTA & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | VFC |
|---|---|---|
| Founded | 2020 | 1899 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.6B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CNTA | VFC |
|---|---|---|
| Price | $39.68 | $16.55 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 18 |
| Target Price | ★ $43.17 | $18.24 |
| AVG Volume (30 Days) | 1.1M | ★ 8.7M |
| Earning Date | 05-13-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.13 | ★ 233.33 |
| EPS | N/A | ★ 0.64 |
| Revenue | $15,000,000.00 | ★ $10,488,556,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.06 |
| P/E Ratio | ★ N/A | $25.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.55 | $11.11 |
| 52 Week High | $40.26 | $22.27 |
Technical Indicators
Market Signals| Indicator | CNTA | VFC |
|---|---|---|
| Relative Strength Index (RSI) | 62.46 | 38.65 |
| Support Level | $39.36 | $15.75 |
| Resistance Level | $39.86 | $17.31 |
| Average True Range (ATR) | 0.13 | 0.70 |
| MACD | -0.15 | -0.02 |
| Stochastic Oscillator | 25.93 | 27.69 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About VFC V.F. Corporation
VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.